Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)

Published on Mar 28, 2020in Intensive Care Medicine17.679
· DOI :10.1007/S00134-020-06022-5
Waleed Alhazzani48
Estimated H-index: 48
(McMaster University),
Morten Hylander Møller30
Estimated H-index: 30
(Copenhagen University Hospital)
+ 33 AuthorsAndrew Rhodes70
Estimated H-index: 70
(St George’s University Hospitals NHS Foundation Trust)
BACKGROUND: The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of a rapidly spreading illness, Coronavirus Disease 2019 (COVID-19), affecting thousands of people around the world. Urgent guidance for clinicians caring for the sickest of these patients is needed. METHODS: We formed a panel of 36 experts from 12 countries. All panel members completed the World Health Organization conflict of interest disclosure form. The panel proposed 53 questions that are relevant to the management of COVID-19 in the ICU. We searched the literature for direct and indirect evidence on the management of COVID-19 in critically ill patients in the ICU. We identified relevant and recent systematic reviews on most questions relating to supportive care. We assessed the certainty in the evidence using the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach, then generated recommendations based on the balance between benefit and harm, resource and cost implications, equity, and feasibility. Recommendations were either strong or weak, or in the form of best practice recommendations. RESULTS: The Surviving Sepsis Campaign COVID-19 panel issued 54 statements, of which 4 are best practice statements, 9 are strong recommendations, and 35 are weak recommendations. No recommendation was provided for 6 questions. The topics were: (1) infection control, (2) laboratory diagnosis and specimens, (3) hemodynamic support, (4) ventilatory support, and (5) COVID-19 therapy. CONCLUSION: The Surviving Sepsis Campaign COVID-19 panel issued several recommendations to help support healthcare workers caring for critically ill ICU patients with COVID-19. When available, we will provide new recommendations in further releases of these guidelines.
Figures & Tables
📖 Papers frequently viewed together
4,015 Citations
1,896 Citations
2,609 Citations
#1Xiaohua ChenH-Index: 2
#2Binghong ZhaoH-Index: 2
Last. Feng Li (WHU: Wuhan University)H-Index: 84
view all 12 authors...
BACKGROUND: Although the detection of SARS-CoV-2 viral load in respiratory specimens has been widely used to diagnose coronavirus disease-19 (COVID-19), it is undeniable that serum SARS-CoV-2 nucleic acid (RNAaemia) could be detected in a fraction of COVID-19 patients. However, it is not clear whether testing for RNAaemia is correlated with the occurrence of cytokine storms or with the specific class of patients. METHODS: This study enrolled 48 patients with COVID-19 admitted to the General Hosp...
434 CitationsSource
#1Yazan Zayed (MSU: Michigan State University)H-Index: 9
#2Momen Banifadel (UT: University of Toledo)H-Index: 6
Last. Dawn-Alita Hernandez (UT: University of Toledo)H-Index: 2
view all 13 authors...
Introduction:Acute hypoxemic respiratory failure (AHRF) is a leading cause of intensive care unit (ICU) admission among immunocompromised patients. Invasive mechanical ventilation is associated wit...
7 CitationsSource
#1Xueting Yao (PKU: Peking University)H-Index: 3
#2Fei Ye (CCDC: Chinese Center for Disease Control and Prevention)H-Index: 10
Last. Dongyang Liu (PKU: Peking University)H-Index: 2
view all 15 authors...
BACKGROUND: The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) first broke out in Wuhan (China) and subsequently spread worldwide. Chloroquine has been sporadically used in treating SARS-CoV-2 infection. Hydroxychloroquine shares the same mechanism of action as chloroquine, but its more tolerable safety profile makes it the preferred drug to treat malaria and autoimmune conditions. We propose that the immunomodulatory effect of hydroxychloroquine also may be useful in controlling t...
1,460 CitationsSource
#1Jian Wu (ZJU: Zhejiang University)H-Index: 105
#1Jian Wu (ZJU: Zhejiang University)H-Index: 8
Last. Lanjuan Li (ZJU: Zhejiang University)H-Index: 90
view all 12 authors...
BACKGROUND: We aimed to report the clinical characteristics of imported coronavirus disease-19 (COVID-19) in Jiangsu Province. METHODS: We retrospectively investigated the clinical, imaging, and laboratory characteristics of confirmed cases of COVID-19 with WHO interim guidance in three Grade A hospitals of Jiangsu from Jan 22 to Feb 14, 2020. Real time RT-PCR was used to detect the new coronavirus in respiratory samples. RESULTS: Of the 80 patients infected with COVID-19, 41 patients were femal...
360 CitationsSource
Last. Jørn Wetterslev (Copenhagen University Hospital)H-Index: 82
view all 6 authors...
Abstract Purpose Intravenous fluids are recommended during the initial management of sepsis, but the quality of evidence is low, and clinical equipoise exists. We aimed to assess patient-important benefits and harms of lower versus higher fluid volumes in adult patients with sepsis. Methods We conducted a systematic review with meta-analysis and trial sequential analysis (TSA) of randomised clinical trials of intravenous fluid volume separation in adult patients with sepsis. We adhered to our pu...
19 CitationsSource
#1Xiaobo Yang (HUST: Huazhong University of Science and Technology)H-Index: 7
#2Yuan Yu (HUST: Huazhong University of Science and Technology)H-Index: 8
Last. You Shang (HUST: Huazhong University of Science and Technology)H-Index: 20
view all 16 authors...
Summary Background An ongoing outbreak of pneumonia associated with the severe acute respiratory coronavirus 2 (SARS-CoV-2) started in December, 2019, in Wuhan, China. Information about critically ill patients with SARS-CoV-2 infection is scarce. We aimed to describe the clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia. Methods In this single-centered, retrospective, observational study, we enrolled 52 critically ill adult patients with SARS-CoV-2 pneumonia who w...
4,791 CitationsSource
#1Ashleigh R. Tuite (U of T: University of Toronto)H-Index: 30
#2David N. Fisman (U of T: University of Toronto)H-Index: 63
88 CitationsSource
#1Yaseen M. Arabi (King Saud bin Abdulaziz University for Health Sciences)H-Index: 82
#2Sarah Shalhoub (UWO: University of Western Ontario)H-Index: 15
Last. Robert A. Fowler (U of T: University of Toronto)H-Index: 62
view all 28 authors...
BACKGROUND: The objective of this study was to evaluate the effect of ribavirin and recombinant interferon (RBV/rIFN) therapy on the outcomes of critically ill patients with Middle East respiratory syndrome (MERS), accounting for time-varying confounders. METHODS: This is a retrospective cohort study of critically ill patients with laboratory-confirmed MERS from 14 hospitals in Saudi Arabia diagnosed between September 2012 and January 2018. We evaluated the association of RBV/rIFN with 90-day mo...
148 CitationsSource
563 CitationsSource
#1Zunyou Wu (CCDC: Chinese Center for Disease Control and Prevention)H-Index: 56
#2Jennifer M. McGoogan (CCDC: Chinese Center for Disease Control and Prevention)H-Index: 17
The Chinese Center for Disease Control and Prevention recently published the largest case series to date of coronavirus disease 2019 (COVID-19) in mainland China (72 314 cases, updated through February 11, 2020). This Viewpoint summarizes key findings from this report and discusses emerging understanding of and lessons from the COVID-19 epidemic.
8,160 CitationsSource
Cited By874
#1Drew Farmer (UPenn: University of Pennsylvania)
#2Jose L. Pascual (UPenn: University of Pennsylvania)H-Index: 28
Last. Lewis J. Kaplan (Society of Critical Care Medicine)H-Index: 29
view all 3 authors...
Abstract null null Responding to the coronavirus disease 2019 pandemic has helped craft a global medical community of medical professional society members and nonmembers alike in ways previously unanticipated. The public-facing elements of medical professional societies include their websites, official organs, and educational elements that have been liberated using a Free Open-Access Medical education approach. Work products including guidelines, blogs, and social media offerings have helped cli...
#1Ranjan K. Mohapatra (Government College)H-Index: 8
#2Kuldeep Dhama (IVRI: Indian Veterinary Research Institute)H-Index: 62
Last. Lucia PintilieH-Index: 8
view all 0 authors...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of ongoing global pandemic of coronavirus disease 2019 (COVID-19), has infected millions of people around the world, especially the elderly and immunocompromised individuals. The infection transmission rate is considered more rapid than other deadly pandemics and severe epidemics encountered earlier, such as Ebola, Zika, Influenza, Marburg, SARS, and MERS. The public health situation therefore is really at a challenging ...
#1Xiujie Li (PolyU: Hong Kong Polytechnic University)H-Index: 1
#2Cheuk Ming Mak (PolyU: Hong Kong Polytechnic University)H-Index: 33
Last. Hai Ming Wong (HKU: University of Hong Kong)H-Index: 23
view all 4 authors...
Abstract null null The exposure risk of droplets and aerosols emitted from the oral cavity to the dental professionals and patients has received more attention especially the ongoing outbreak of COVID-19. The aim of this study is to address the question about how the use of the high-volume evacuation (HVE) alters the risk profiles compared with the situation only personal protective equipment (PPE). The risk profiles of the different situations were analyzed in terms of droplet velocity, flow fi...
#1T. M. Cook (UoB: University of Bristol)H-Index: 11
#2Luigi Camporota (Guy's and St Thomas' NHS Foundation Trust)H-Index: 26
#1Daniela Pasero (University of Sassari)H-Index: 18
#2A.P. CossuH-Index: 4
Last. Pierpaolo Terragni (University of Sassari)H-Index: 18
view all 0 authors...
Introduction. It is known that bacterial infections represent a common complication during viral respiratory tract infections such as influenza, with a concomitant increase in morbidity and mortality. Nevertheless, the prevalence of bacterial co-infections and secondary infections in critically ill patients affected by coronavirus disease 2019 (COVID-19) is not well understood yet. We performed a review of the literature currently available to examine the incidence of bacterial secondary infecti...
Last. Josiane Santos Silva (State University of Piauí)H-Index: 1
view all 0 authors...
Background. Since December 2019, the new coronavirus disease 2019 (COVID-19) has been marching confidently and aggressively across the planet. On March 11, 2020, the World Health Organization has declared COVID-19 a pandemic. Among the risk factors for the development and severe course of COVID-19, there are old age, arterial hypertension, diabetes mellitus, chronic obstructive pulmonary disease, cardiovascular and cerebrovascular diseases. However, recently, based on the epidemiological data ob...
Last. Josiane Santos Silva (State University of Piauí)H-Index: 1
view all 0 authors...
#1Mustafa Altinay (UHSA: University of Health Sciences Antigua)H-Index: 1
#2İsmet Sayan (UHSA: University of Health Sciences Antigua)
Last. Ilay Cetiner (UHSA: University of Health Sciences Antigua)
view all 0 authors...
Background null We evaluated the effect of early awake prone position administration on oxygenation and intubation requirements and short-term mortality in patients with acute respiratory failure due to coronavirus disease 2019 (COVID-19) pneumonia. null Methods null This is an observational-cohort study. Patients receiving mask oxygen therapy in our intensive care units because of acute respiratory failure due to COVID-19 pneumonia were included. The Awake Prone Position (APP) group consisted o...